Somerset Therap Company Profile
What is the competitive landscape for SOMERSET THERAP
SOMERSET THERAP has ninety-six approved drugs.
Summary for Somerset Therap
| US Patents: | 0 |
| Tradenames: | 86 |
| Ingredients: | 85 |
| NDAs: | 96 |
| Patent Litigation for Somerset Therap: | See patent lawsuits for Somerset Therap |
Drugs and US Patents for Somerset Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | MOXIFLOXACIN HYDROCHLORIDE | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209698-001 | Nov 14, 2024 | AT1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210558-001 | Jul 12, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | INJECTABLE;INJECTION | 214333-001 | Nov 1, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 206791-001 | Feb 20, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

